Arama Sonuçları - "Lu'an"

The Lu Lu Alphabet Yazar: Colman, Miss (Pamela Atkins), 1824-1900

Tam Metin Erişim

Improved quality control of [177Lu]Lu-PSMA I&T Yazar: Martin Kraihammer, Piotr Garnuszek, Andreas Bauman, Michael Maurin, Manuel Alejandre Lafont, Roland Haubner, Elisabeth von Guggenberg, Michael Gabriel, Clemens Decristoforo

Connect to this object online.

Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies Yazar: Alexander Wurzer, Francesco De Rose, Sebastian Fischer, Markus Schwaiger, Wolfgang Weber, Stephan Nekolla, Hans-Jürgen Wester, Matthias Eiber, Calogero D'Alessandria

Connect to this object online.

First-In-Human Results on the Biodistribution, Pharmacokinetics, and Dosimetry of [¹⁷⁷Lu]Lu-DOTA.SA.FAPi and [¹⁷⁷Lu]Lu-DOTAGA.... Yazar: Sanjana Ballal, Madhav Prasad Yadav, Euy Sung Moon, Vasko S Kramer, Frank Roesch, Samta Kumari, Chandrasekhar Bal

Connect to this object online.

Distinct In Vitro Binding Profile of the Somatostatin Receptor Subtype 2 Antagonist [¹⁷⁷Lu]Lu-OPS201 Compared to the Agonist [¹⁷⁷Lu]Lu-DOTA-TATE Yazar: Rosalba Mansi, Pascale Plas, Georges Vauquelin, Melpomeni Fani

Connect to this object online.

Evaluation of the 177mLu-concentration in in-house produced 177Lu-radiopharmaceuticals and commercially available Lutathera® Yazar: Matthias Balzer, Fleur Spiecker, Stephanie Bluemel, Holger Amthauer, Winfried Brenner, Sarah Spreckelmeyer

Connect to this object online.

Chilean experience using "Theranostics" for treating metastatic neuroendocrine tumors with [177Lu]Lu DOTA-TATE Yazar: Horacio Amaral, Rossana Pruzzo, René Fernández, Vasko Kramer, Cristian Soza-Ried, Irene Coudeu

Connect to this object online.

The development of information in daily life / Puteri Lu'lu Fahrin Shah and Nur Hidayyah Shari Shawarudin Yazar: Fahrin Shah, Puteri Lu'lu, Shari Shawarudin, Nur Hidayyah

Link Metadata

Quality control of [177Lu]Lu-PSMA preparations using HPLC: effect of sample composition and ligand on recovery Yazar: Else A. Aalbersberg, Tammie T. Cao, Martine M. Geluk-Jonker, Jeroen J. M. A. Hendrikx

Connect to this object online.

Characterization of Non-Specific Uptake and Retention Mechanisms of [¹⁷⁷Lu]Lu-PSMA-617 in the Salivary Glands Yazar: Nathalie Heynickx, Charlotte Segers, Amelie Coolkens, Sarah Baatout, Koen Vermeulen

Connect to this object online.

Radionuclide generator-based production of therapeutic 177Lu from its long-lived isomer 177mLu Yazar: Rupali Bhardwaj, Hubert Th. Wolterbeek, Antonia G. Denkova, Pablo Serra-Crespo

Connect to this object online.

Comparison of the Anti-Tumour Activity of the Somatostatin Receptor (SST) Antagonist [¹⁷⁷Lu]Lu-Satoreotide Tetraxetan and the Agonist [¹⁷⁷Lu]Lu-DOTA-TATE in Mice Bearing AR42J SST₂-Positive Tumours Yazar: Pascale Plas, Lorenzo Limana, Denis Carré, Amath Thiongane, Olivier Raguin, Rosalba Mansi, Florence Meyer-Losic, Stéphane Lezmi

Connect to this object online.

A glimpse into Lu Xun and Chinese medicine Yazar: Jin Ye

Connect to this object online.

[¹⁷⁷Lu]Lu-PSMA-617 Salivary Gland Uptake Characterized by Quantitative <i>In Vitro</i> Autoradiography Yazar: Roswitha Tönnesmann, Philipp T. Meyer, Matthias Eder, Ann-Christin Baranski

Connect to this object online.

In vitro characterisation of [177Lu]Lu-DOTA-C595 as a novel radioimmunotherapy for MUC1-CE positive pancreatic cancer Yazar: Ashleigh Hull, William Hsieh, William Tieu, Dylan Bartholomeusz, Yanrui Li, Eva Bezak

Connect to this object online.

Potential role of Lu/BCAM in HIV-related atherosclerosis Yazar: Modisa S. Motswaledi, Ishmael Kasvosve, Oluwafemi O. Oguntibeju

Connect to this object online.

First person - Manh Tin Ho and Jiongming Lu

Connect to this object online.

Radiolabeling and quality control of therapeutic radiopharmaceuticals: optimization, clinical implementation and comparison of radio-TLC/HPLC analysis, demonstrated by [177Lu]Lu-PSMA Yazar: Eline L. Hooijman, Carolline M. Ntihabose, Thom G. A. Reuvers, Julie Nonnekens, Else A. Aalbersberg, Jordy R. J. P. van de Merbel, Judith E. Huijmans, Stijn L. W. Koolen, Jeroen J. M. A. Hendrikx, Erik de Blois

Connect to this object online.

[¹⁷⁷Lu]Lu-PSMA-617 (Pluvicto^TM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer Yazar: Ute Hennrich, Matthias Eder

Connect to this object online.

RadioLigand Therapy with [¹⁷⁷Lu]Lu-PSMA-617 for Salivary Gland Cancers: Literature Review and First Compassionate Use in France Yazar: Marie Terroir, Chloé Lamesa, Mehdi Krim, Lavinia Vija, Jean-Sébastien Texier, Thibaut Cassou-Mounat, Jean-Pierre Delord, Delphine Vallot, Frédéric Courbon

Connect to this object online.